U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457541) titled 'Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI' on March 03.
Brief Summary: The study should evaluate the biological distribution of 99mTc-HYNIC-FAPI in metastatic cancer patients.
Study Start Date: Feb. 26
Study Type: INTERVENTIONAL
Condition:
Lung Cancer (Locally Advanced or Metastatic)
Pancreas Cancer, Metastatic
Breast Cancer (Locally Advanced or Metastatic)
Colorectal Cancer (Locally Advanced or Metastatic)
Intervention:
DRUG: [99mTc]Tc-HYNIC-FAPI
One single intravenous injection of [99mTc]Tc-HYNIC-FAPI, followed by gamma camera imaging after 2, 4, 6 and 24 hours.
...